Imolamine
CARDIOVASCULAR SYSTEM
Also known as: imolamine HCl, imolamine hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Imolamine is a drug catalogued in DrugCentral. Recorded indications include Angina pectoris.
- Indications: Angina pectoris.
- ATC code: C01DX09 (Other vasodilators used in cardiac diseases).
- Molecular formula: C14H20N4O; molecular weight 260.34 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Angina pectoris
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01DX09 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › VASODILATORS USED IN CARDIAC DISEASES › Other vasodilators used in cardiac diseases |
Chemical structure
| Molecular formula | C14H20N4O |
|---|---|
| Molecular weight | 260.34 g/mol |
| CAS number | — |
| InChIKey | MGSPDRWOUCPKNZ-UHFFFAOYSA-N |
| PubChem CID | 27501 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Imolamine used for?
DrugCentral lists the following indications for Imolamine: Angina pectoris.
What is the chemical formula of Imolamine?
Imolamine has the molecular formula C14H20N4O and a molecular weight of 260.34 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1430 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104282 — compound record and bioactivity
- PubChem CID 27501 — chemical identifiers
- DrugBank DB09284 — drug record
- FDA UNII K5F4RU5VQJ — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.